TrialJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2023

The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.

Thomas J Altree et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.